# Multispecies Probiotic Supplementation in Chronic Kidney Disease (CKD): Insights From Indian Nephrology Experts

**Authors:** Pankaj Beniwal, Manish Singla, Deba Prasad Kar, Vinant Bhargava, Naman Chandra, DK Sinha, Vivek Ruhela, Rathan Jha, Rajesh Joseph, Vishnu RS, Nitin Bhosle, Kapil Mehta, Sarita Bajpai

PMC · DOI: 10.7759/cureus.102520 · Cureus · 2026-01-28

## TL;DR

Indian nephrology experts suggest that multispecies probiotics may help CKD patients by improving gut health and reducing toxins.

## Contribution

The paper provides expert insights on the potential benefits of multispecies probiotics for CKD management in the Indian context.

## Key findings

- Multispecies probiotics reduce uremic toxins and improve gut integrity in CKD patients.
- Probiotic strains like Lactobacillus acidophilus and Bifidobacterium longum show antimicrobial effects and inflammation reduction.
- Probiotics may delay CKD progression and improve quality of life for patients in stages 3 to 5.

## Abstract

Chronic kidney disease (CKD) is a progressive condition leading to the accumulation of uremic toxins and systemic complications, eventually resulting in loss of kidney function. One of the major mechanisms behind the CKD complications is gut dysbiosis, a commotion in the gut micro-ecology that aggravates systemic inflammation and worsens the CKD management. Probiotics, through their ability to restore gut micro-ecology, strengthen the intestinal barrier integrity, modulate the immune system, and mitigate systemic inflammation, offer a promising add-on therapy to traditional CKD therapies. Specific probiotic strains, including Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacterium longum, and Bacillus coagulans, have demonstrated antimicrobial effects by promoting commensal bacterial growth and inhibiting pathogenic bacterial growth. Studies indicate that these probiotics reduce uremic toxin levels, such as indoxyl sulfate and p-cresyl sulfate, blood urea nitrogen, urea, and creatinine levels, enhance gut integrity, alleviate inflammation, and are beneficial for patients with CKD stages 3 to 5. While the evidence for probiotic supplementation is promising, further studies are required to establish their long-term benefits, especially in patients with immune deficiency or kidney transplants. Overall, this consensus article provides insights from Indian nephrology experts on the potential benefits of multispecies probiotic supplementation in CKD patients, focusing on improving their quality of life, delaying disease progression, and ultimately augmenting survival outcomes.

## Linked entities

- **Chemicals:** indoxyl sulfate (PubChem CID 10258), p-cresyl sulfate (PubChem CID 4615423), urea (PubChem CID 1176), creatinine (PubChem CID 588)
- **Diseases:** chronic kidney disease (MONDO:0005300)
- **Species:** Streptococcus thermophilus (taxon 1308), Lactobacillus acidophilus (taxon 1579), Bifidobacterium longum (taxon 216816)

## Full-text entities

- **Genes:** IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, CD14 (CD14 molecule) [NCBI Gene 929], mucin [NCBI Gene 100508689], PCS [NCBI Gene 8075], SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}
- **Diseases:** loss of appetite (MESH:D001068), constipation (MESH:D003248), kidney (MESH:D007674), type 2 diabetic (MESH:D003924), sepsis (MESH:D018805), endotoxemia (MESH:D019446), anemia (MESH:D000740), bone disorders (MESH:D001847), weight loss (MESH:D015431), ESRD (MESH:D007676), immune deficiency (MESH:D007154), uremic (MESH:D006463), infection (MESH:D007239), cardiovascular disease (MESH:D002318), overweight (MESH:D050177), fatigue (MESH:D005221), nausea (MESH:D009325), obese (MESH:D009765), weight gain (MESH:D015430), decline in kidney function (MESH:D007680), inflammation (MESH:D007249), Uremia (MESH:D014511), gastrointestinal symptoms (MESH:D012817), anorexia (MESH:D000855), CKD (MESH:D051436), IS (MESH:C563094), dysbiosis (MESH:D064806), kidney failure (MESH:D051437)
- **Chemicals:** p-cresol (MESH:C032538), LPS (MESH:D008070), SCFA (MESH:D005232), creatinine (MESH:D003404), indole (MESH:C030374), IAA (MESH:C030737), acetate (MESH:D000085), IS (MESH:D007200), BGN4 (-), carbohydrates (MESH:D002241), propionate (MESH:D011422), urea (MESH:D014508), butyrate (MESH:D002087), iron (MESH:D007501), ammonia (MESH:D000641), TMAO (MESH:C005855), phosphate (MESH:D010710), uric acid (MESH:D014527), p-cresyl sulfate (MESH:C408690), indoxyl glucuronide (MESH:C059836)
- **Species:** Bifidobacterium animalis (species) [taxon 28025], Bifidobacterium bifidum (species) [taxon 1681], Lactiplantibacillus plantarum (species) [taxon 1590], Streptococcus thermophilus (species) [taxon 1308], Lacticaseibacillus casei (species) [taxon 1582], Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Lactobacillales (order) [taxon 186826], Lactobacillus acidophilus (species) [taxon 1579], Lacticaseibacillus paracasei (species) [taxon 1597], Lactococcus lactis (species) [taxon 1358], Bifidobacterium catenulatum (species) [taxon 1686], Heyndrickxia coagulans (species) [taxon 1398], Bifidobacterium longum (species) [taxon 216816], Lacticaseibacillus rhamnosus (species) [taxon 47715]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949327/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949327/full.md

---
Source: https://tomesphere.com/paper/PMC12949327